Predictors of consent to pharmacogenomics testing in the IDEAL study
Alison B Jazwinski, Paul J Clark, Alexander J Thompson, Stuart C Gordon, Eric J Lawitz, Stephanie Noviello, Clifford A Brass, Lisa D Pedicone, Janice K Albrecht, Mark S Sulkowski, Andrew J Muir
Pharmacogenetics and Genomics | LIPPINCOTT WILLIAMS & WILKINS | Published : 2013
Awarded by Duke Training Grant in Digestive Diseases and Nutrition
The IDEAL study was sponsored by Schering-Plough (now Merck & Co. Inc.).Editorial assistance was provided by Tim Ibbotson, PhD, and Bianca Ruzicka, PhD, of ApotheCom (Yardley, PA). This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc., Whitehouse Station, NJ.A.B.J. received the Duke Training Grant in Digestive Diseases and Nutrition during the period from 1 July 2010 to 30 June 2011 (#NIH 5T32DK007568-20).